{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:28:09Z","timestamp":1759332489058,"version":"3.37.3"},"reference-count":81,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,13]],"date-time":"2016-10-13T00:00:00Z","timestamp":1476316800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008017","name":"Flinders Medical Centre Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008017","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Faculty of Health Sciences of Flinders University"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","pathologyjournal.rcpa.edu.au","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.pathol.2016.07.009","type":"journal-article","created":{"date-parts":[[2016,10,29]],"date-time":"2016-10-29T05:45:11Z","timestamp":1477719911000},"page":"650-659","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Vasculogenic mimicry in malignant mesothelioma: an experimental and immunohistochemical analysis"],"prefix":"10.1016","volume":"48","author":[{"given":"Emily","family":"Pulford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ashleigh","family":"Hocking","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Griggs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"McEvoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudine","family":"Bonder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Douglas W.","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonja","family":"Klebe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2016.07.009_bib1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.5694\/mja11.10899","article-title":"Medicolegal aspects of the third wave of asbestos-related disease in Australia","volume":"195","author":"Gordon","year":"2011","journal-title":"Med J Aust"},{"key":"10.1016\/j.pathol.2016.07.009_bib2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/1753-6405.12503","article-title":"Patterns in the incidence, mortality and survival of malignant pleural and peritoneal mesothelioma, New South Wales, 1972\u20132009","volume":"40","author":"Soeberg","year":"2016","journal-title":"Aust NZ J Public Health"},{"key":"10.1016\/j.pathol.2016.07.009_bib3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1136\/oemed-2015-103309","article-title":"Incidence and survival trends for malignant pleural and peritoneal mesothelioma, Australia, 1982\u20132009","volume":"73","author":"Soeberg","year":"2016","journal-title":"Occup Environ Med"},{"key":"10.1016\/j.pathol.2016.07.009_bib4","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S1470-2045(05)70471-X","article-title":"Survival from rare cancer in adults: a population-based study","volume":"7","author":"Gatta","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.pathol.2016.07.009_bib5","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1054\/bjoc.2001.1997","article-title":"Angiogenesis is an independent prognostic factor in malignant mesothelioma","volume":"85","author":"Edwards","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pathol.2016.07.009_bib6","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/(SICI)1096-9896(199706)182:2<211::AID-PATH834>3.0.CO;2-D","article-title":"Evaluation of tumour angiogenesis as a prognostic marker in malignant mesothelioma","volume":"182","author":"Kumar-Singh","year":"1997","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.pathol.2016.07.009_bib7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.clon.2004.01.013","article-title":"Determination of tumour prognosis based on angiogenesis-related vascular patterns measured by fractal and syntactic structure analysis","volume":"16","author":"Weyn","year":"2004","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.pathol.2016.07.009_bib8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.rmed.2010.10.010","article-title":"Pleural effusion VEGF levels as a prognostic factor of malignant pleural mesothelioma","volume":"105","author":"Hirayama","year":"2011","journal-title":"Respir Med"},{"key":"10.1016\/j.pathol.2016.07.009_bib9","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.lungcan.2011.06.007","article-title":"The predictive role of serum VEGF in an advanced malignant mesothelioma patient cohort treated with thalidomide alone or combined with cisplatin\/gemcitabine","volume":"75","author":"Kao","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.pathol.2016.07.009_bib10","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S0002-9440(10)65173-5","article-title":"Vascular channel formation by human melanoma cells in\u00a0vivo and in\u00a0vitro: vasculogenic mimicry","volume":"155","author":"Maniotis","year":"1999","journal-title":"Am J Pathol"},{"key":"10.1016\/j.pathol.2016.07.009_bib11","first-page":"560","article-title":"Hemodynamics in vasculogenic mimicry and angiogenesis of inflammatory breast cancer xenograft","volume":"62","author":"Shirakawa","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.pathol.2016.07.009_bib12","first-page":"5381","article-title":"Differential role of tissue factor pathway inhibitors 1 and 2 in melanoma vasculogenic mimicry","volume":"63","author":"Ruf","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.pathol.2016.07.009_bib13","first-page":"2812","article-title":"\u201cVasocrine\u201d formation of tumor cell-lined vascular spaces: implications for rational design of antiangiogenic therapies","volume":"63","author":"Rybak","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/j.pathol.2016.07.009_bib14","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.bbrc.2008.01.080","article-title":"A\u00a0transgenic Tie2-GFP athymic mouse model; a tool for vascular biology in xenograft tumors","volume":"368","author":"Hillen","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.pathol.2016.07.009_bib15","doi-asserted-by":"crossref","first-page":"5200","DOI":"10.1038\/ncomms6200","article-title":"Vascular channels formed by subpopulations of PECAM1+ melanoma cells","volume":"5","author":"Dunleavey","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.pathol.2016.07.009_bib16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s12253-009-9220-7","article-title":"Vasculogenic mimicry: a new prognostic sign of gastric adenocarcinoma","volume":"16","author":"Li","year":"2010","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.pathol.2016.07.009_bib17","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrc1092","article-title":"Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma","volume":"3","author":"Hendrix","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.pathol.2016.07.009_bib18","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1158\/1078-0432.CCR-11-3237","article-title":"Molecular pathways: vasculogenic mimicry in tumor cells: diagnostic and therapeutic implications","volume":"18","author":"Kirschmann","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2016.07.009_bib19","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1016\/j.ejca.2013.07.148","article-title":"Tumour vasculogenic mimicry is associated with poor prognosis of human cancer patients: a systemic review and meta-analysis","volume":"49","author":"Cao","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.pathol.2016.07.009_bib20","doi-asserted-by":"crossref","first-page":"19634","DOI":"10.3390\/ijms151119634","article-title":"OCT4 expression and vasculogenic mimicry formation positively correlate with poor prognosis in human breast cancer","volume":"15","author":"Liu","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.pathol.2016.07.009_bib21","first-page":"5782","article-title":"Association of Notch1 with vasculogenic mimicry in human hepatocellular carcinoma cell lines","volume":"7","author":"Zhu","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.pathol.2016.07.009_bib22","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1158\/1535-7163.MCT-14-0523","article-title":"Rho Kinase inhibitor Fasudil suppresses the vasculogenic mimicry of B16 mouse melanoma cells both in\u00a0vitro and in\u00a0vivo","volume":"14","author":"Xia","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.pathol.2016.07.009_bib23","first-page":"4033","article-title":"Erythropoietin and erythropoietin receptor in hepatocellular carcinoma: correlation with vasculogenic mimicry and poor prognosis","volume":"8","author":"Yang","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.pathol.2016.07.009_bib24","first-page":"1609","article-title":"Vasculogenic mimicry is associated with poor survival in patients with mesothelial sarcomas and alveolar rhabdomyosarcomas","volume":"25","author":"Sun","year":"2004","journal-title":"Int J Oncol"},{"key":"10.1016\/j.pathol.2016.07.009_bib25","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/sj.bjc.6690650","article-title":"VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours","volume":"81","author":"Ohta","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pathol.2016.07.009_bib26","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.lungcan.2012.03.006","article-title":"VEGF and sVEGFR-1 in malignant pleural effusions: Association with survival and pleurodesis outcomes","volume":"77","author":"Hooper","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.pathol.2016.07.009_bib27","first-page":"3364","article-title":"Vascular endothelial growth factor levels and induction of permeability in malignant pleural effusions","volume":"5","author":"Zebrowski","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2016.07.009_bib28","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1159\/000029460","article-title":"Co-expression of vascular endothelial growth factor and its receptor flt-1 in malignant pleural mesothelioma","volume":"67","author":"Konig","year":"2000","journal-title":"Respiration"},{"key":"10.1016\/j.pathol.2016.07.009_bib29","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/path.824","article-title":"Vascular endothelial growth factor is an autocrine growth factor in human malignant mesothelioma","volume":"193","author":"Strizzi","year":"2001","journal-title":"J\u00a0Pathol"},{"key":"10.1016\/j.pathol.2016.07.009_bib30","doi-asserted-by":"crossref","first-page":"5918","DOI":"10.1158\/1078-0432.CCR-07-0501","article-title":"The therapeutic efficacy of anti vascular endothelial growth factor antibody, bevacizumab, and pemetrexed against orthotopically implanted human pleural mesothelioma cells in severe combined immunodeficient mice","volume":"13","author":"Li","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2016.07.009_bib31","series-title":"Malignant Mesothelioma","first-page":"69","article-title":"The pathology of mesothelioma, including immunohistology and ultrastructure","author":"Henderson","year":"1992"},{"key":"10.1016\/j.pathol.2016.07.009_bib32","series-title":"Dail and Hammar's Pulmonary Pathology","first-page":"558","article-title":"Neoplasms of the pleura","volume":"Vol 2","author":"Hammar","year":"2008"},{"key":"10.1016\/j.pathol.2016.07.009_bib33","first-page":"1","article-title":"Guidelines for Pathologic Diagnosis of Malignant Mesothelioma: 2012 Update of the Consensus Statement from the International Mesothelioma Interest Group","volume":"136","author":"Husain","year":"2012","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.pathol.2016.07.009_bib34","series-title":"Pathology of Asbestos-Associated Diseases","first-page":"81","article-title":"Mesothelioma","author":"Pavlisko","year":"2014"},{"key":"10.1016\/j.pathol.2016.07.009_bib35","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1038\/modpathol.2008.125","article-title":"Malignant mesothelioma with heterologous elements: clinicopathological correlation of 27 cases and literature review","volume":"21","author":"Klebe","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2016.07.009_bib36","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1136\/jcp.50.10.859","article-title":"HBME-1 and antithrombomodulin in the differential diagnosis of malignant mesothelioma of pleura","volume":"50","author":"Kennedy","year":"1997","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.pathol.2016.07.009_bib37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1365-2559.1997.6020829.x","article-title":"Value of thrombomodulin immunostaining in the diagnosis of mesothelioma","volume":"31","author":"Ordonez","year":"1997","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2016.07.009_bib38","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/(SICI)1097-0142(19980425)84:2<101::AID-CNCR6>3.0.CO;2-S","article-title":"Utility of the antibodies CA 19-9, HBME-1, and thrombomodulin in the diagnosis of malignant mesothelioma and adenocarcinoma in cytology","volume":"84","author":"Fetsch","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/j.pathol.2016.07.009_bib39","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/modpathol.3880018","article-title":"Value of the mesothelium-associated antibodies thrombomodulin, cytokeratin 5\/6, calretinin, and CD44H in distinguishing epithelioid pleural mesothelioma from adenocarcinoma metastatic to the pleura","volume":"13","author":"Cury","year":"2000","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2016.07.009_bib40","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1053\/hupa.2001.24329","article-title":"Calretinin, thrombomodulin, CEA, and CD15: a useful combination of immunohistochemical markers for differentiating pleural epithelial mesothelioma from peripheral pulmonary adenocarcinoma","volume":"32","author":"Comin","year":"2001","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2016.07.009_bib41","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/modpathol.2011.144","article-title":"Epithelial-mesenchymal transition in malignant mesothelioma","volume":"25","author":"Fassina","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2016.07.009_bib42","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1158\/1078-0432.CCR-13-2429","article-title":"Molecular classification of malignant pleural mesothelioma: identification of a poor prognosis subgroup linked to the epithelial-to-mesenchymal transition","volume":"20","author":"de Reynies","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2016.07.009_bib43","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1083\/jcb.139.1.219","article-title":"Novel cytokine-independent induction of endothelial adhesion molecules regulated by platelet\/endothelial cell adhesion molecule (CD31)","volume":"139","author":"Litwin","year":"1997","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.pathol.2016.07.009_bib44","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jtho.2015.11.005","article-title":"The 2015 World Health Organization Classification of Tumors of the Pleura: Advances since the 2004 Classification","volume":"11","author":"Galateau-Salle","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.pathol.2016.07.009_bib45","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1097\/00000478-199612000-00001","article-title":"Malignant vascular tumors of the serous membranes mimicking mesothelioma. A report of 14 cases","volume":"20","author":"Lin","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2016.07.009_bib46","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/00005382-200307000-00011","article-title":"Pseudomesotheliomatous angiosarcoma of the chest wall and pleura","volume":"18","author":"Del Frate","year":"2003","journal-title":"J\u00a0Thorac Imaging"},{"key":"10.1016\/j.pathol.2016.07.009_bib47","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1746-1596-6-130","article-title":"Primary pleural angiosarcoma as a mimicker of mesothelioma: a case report","volume":"6","author":"Kao","year":"2011","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.pathol.2016.07.009_bib48","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1177\/0192623311430695","article-title":"The utility of immunohistochemistry for the identification of hematopoietic and lymphoid cells in normal tissues and interpretation of proliferative and inflammatory lesions of mice and rats","volume":"40","author":"Rehg","year":"2012","journal-title":"Toxicol Pathol"},{"key":"10.1016\/j.pathol.2016.07.009_bib49","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1097\/PAS.0b013e318206b67b","article-title":"ERG transcription factor as an immunohistochemical marker for vascular endothelial tumors and prostatic carcinoma","volume":"35","author":"Miettinen","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2016.07.009_bib50","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1136\/jclinpath-2014-202629","article-title":"The utility of ERG, CD31 and CD34 in the cytological diagnosis of angiosarcoma: an analysis of 25 cases","volume":"68","author":"Sullivan","year":"2015","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.pathol.2016.07.009_bib51","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/modpathol.2009.47","article-title":"TLE1 expression is not specific for synovial sarcoma: a whole section study of 163 soft tissue and bone neoplasms","volume":"22","author":"Kosemehmetoglu","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2016.07.009_bib52","first-page":"766","article-title":"Immunohistochemical validation of TLE1, a novel marker, for synovial sarcomas","volume":"136","author":"Rekhi","year":"2012","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.pathol.2016.07.009_bib53","doi-asserted-by":"crossref","first-page":"106","DOI":"10.5858\/arpa.2014-0488-RA","article-title":"An update on the application of newly described immunohistochemical markers in soft tissue pathology","volume":"139","author":"Lin","year":"2015","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.pathol.2016.07.009_bib54","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00428-010-0975-8","article-title":"TLE1 expression in malignant mesothelioma","volume":"457","author":"Matsuyama","year":"2010","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2016.07.009_bib55","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1046\/j.1365-2559.2002.01451.x","article-title":"Malignant mesothelioma: PAS-diastase positivity and inversion of polarity in intravascular tumour","volume":"41","author":"Adams","year":"2002","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2016.07.009_bib56","first-page":"11","article-title":"Immunoreactivity in malignant mesotheliomas with antibodies to basement membrane components and their receptors","volume":"3","author":"Kallianpur","year":"1990","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2016.07.009_bib57","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1158\/1078-0432.CCR-11-2900","article-title":"Human prostate cancer in a clinically relevant xenograft mouse model: identification of beta(1,6)-branched oligosaccharides as a marker of tumor progression","volume":"18","author":"Lange","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.pathol.2016.07.009_bib58","doi-asserted-by":"crossref","first-page":"8499","DOI":"10.1007\/s13277-015-3508-x","article-title":"Combretastatin A4 phosphate treatment\u00a0induces vasculogenic mimicry formation of W256 breast carcinoma tumor in\u00a0vitro and in\u00a0vivo","volume":"36","author":"Yao","year":"2015","journal-title":"Tumour Biol"},{"key":"10.1016\/j.pathol.2016.07.009_bib59","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1369\/jhc.4A6521.2005","article-title":"Does vasculogenic mimicry exist in astrocytoma?","volume":"53","author":"Yue","year":"2005","journal-title":"J\u00a0Histochem Cytochem"},{"key":"10.1016\/j.pathol.2016.07.009_bib60","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/brain\/awq044","article-title":"A\u00a0new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry","volume":"133","author":"El Hallani","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.pathol.2016.07.009_bib61","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/nature09557","article-title":"Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells","volume":"468","author":"Ricci-Vitiani","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2016.07.009_bib62","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2174\/156720211796558023","article-title":"CD133+ glioblastoma stem-like cells induce vascular mimicry in\u00a0vivo","volume":"8","author":"Chiao","year":"2011","journal-title":"Curr Neurovasc Res"},{"key":"10.1016\/j.pathol.2016.07.009_bib63","doi-asserted-by":"crossref","first-page":"24821","DOI":"10.1074\/jbc.M111.334540","article-title":"Glioblastoma-derived tumor cells induce vasculogenic mimicry through Flk-1 protein activation","volume":"287","author":"Francescone","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.pathol.2016.07.009_bib64","doi-asserted-by":"crossref","first-page":"12950","DOI":"10.1523\/JNEUROSCI.2017-12.2012","article-title":"Transdifferentiation of glioblastoma stem-like cells into mural cells drives vasculogenic mimicry in glioblastomas","volume":"32","author":"Scully","year":"2012","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.pathol.2016.07.009_bib65","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/neuonc\/not029","article-title":"CDH5 is specifically activated in glioblastoma stemlike cells and contributes to vasculogenic mimicry induced by hypoxia","volume":"15","author":"Mao","year":"2013","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.pathol.2016.07.009_bib66","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s11060-013-1077-7","article-title":"Vasculogenic mimicry is a prognostic factor for postoperative survival in patients with glioblastoma","volume":"112","author":"Wang","year":"2013","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.pathol.2016.07.009_bib67","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s40364-015-0034-3","article-title":"Glioblastoma vasculogenic mimicry: signaling pathways progression and potential anti-angiogenesis targets","volume":"3","author":"Mao","year":"2015","journal-title":"Biomark Res"},{"key":"10.1016\/j.pathol.2016.07.009_bib68","doi-asserted-by":"crossref","first-page":"40507","DOI":"10.18632\/oncotarget.5943","article-title":"Vascular heterogeneity and targeting: the role of YKL-40 in glioblastoma vascularization","volume":"6","author":"Shao","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.pathol.2016.07.009_bib69","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1111\/j.1365-2559.2012.04220.x","article-title":"Diffuse pleural mesothelioma with epithelioid and angiosarcomatous components \u2013 a hitherto undescribed pattern of differentiation","volume":"60","author":"Klabatsa","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2016.07.009_bib70","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1038\/modpathol.3800616","article-title":"D2-40 antibody immunoreactivity in developing human brain, brain tumors and cultured neural cells","volume":"19","author":"Nakamura","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2016.07.009_bib71","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/PAP.0b013e3181915e94","article-title":"D2-40 immunohistochemistry \u2013 so far!","volume":"16","author":"Kalof","year":"2009","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.pathol.2016.07.009_bib72","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0046-8177(00)80194-X","article-title":"Malignant epithelioid vascular tumors of the pleura: report of a series and literature review","volume":"31","author":"Zhang","year":"2000","journal-title":"Hum Pathol"},{"key":"10.1016\/j.pathol.2016.07.009_bib73","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1136\/thorax.55.10.860","article-title":"Malignant vascular tumours of the pleura in \u201casbestos\u201d workers and endothelial differentiation in malignant mesothelioma","volume":"55","author":"Attanoos","year":"2000","journal-title":"Thorax"},{"key":"10.1016\/j.pathol.2016.07.009_bib74","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3346\/jkms.2001.16.6.792","article-title":"Epithelioid angiosarcoma of the pleura: a case report","volume":"16","author":"Roh","year":"2001","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1016\/j.pathol.2016.07.009_bib75","first-page":"304","article-title":"Angiosarcoma of serous membranes","volume":"107","author":"McCaughey","year":"1983","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.pathol.2016.07.009_bib76","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1046\/j.1365-2559.1997.5370782.x","article-title":"Pseudomesotheliomatous angiosarcoma: a pleuropulmonary lesion simulating malignant pleural mesothelioma","volume":"30","author":"Falconieri","year":"1997","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2016.07.009_bib77","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.1167\/iovs.14-14706","article-title":"Mesothelial cells: a cellular surrogate for tissue engineering of corneal endothelium","volume":"55","author":"Lachaud","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.pathol.2016.07.009_bib78","first-page":"1345","article-title":"An autopsy case of primary angiosarcoma of the pericardium mimicking malignant mesothelioma","volume":"38","author":"Terada","year":"1988","journal-title":"Acta Pathol Jpn"},{"key":"10.1016\/j.pathol.2016.07.009_bib79","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1365-2559.1992.tb00430.x","article-title":"Intermediate filament expression in mesotheliomas: Leiomyoid mesotheliomas are not uncommon","volume":"21","author":"Mayall","year":"1992","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2016.07.009_bib80","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/modpathol.2009.180","article-title":"Sarcomatoid mesothelioma: a clinical-pathologic correlation of 326 cases","volume":"23","author":"Klebe","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2016.07.009_bib81","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1365-2559.2003.01686.x","article-title":"The use of immunohistochemistry in distinguishing reactive from neoplastic mesothelium. A novel use for desmin and comparative evaluation with epithelial membrane antigen, p53, platelet-derived growth factor-receptor, P-glycoprotein and Bcl-2","volume":"43","author":"Attanoos","year":"2003","journal-title":"Histopathology"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516402229?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302516402229?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T15:00:56Z","timestamp":1617634856000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302516402229"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":81,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S0031302516402229"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2016.07.009","relation":{},"ISSN":["0031-3025"],"issn-type":[{"type":"print","value":"0031-3025"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vasculogenic mimicry in malignant mesothelioma: an experimental and immunohistochemical analysis","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2016.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Royal College of Pathologists of Australasia. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}